Although no significant independent prognostic effects of the three PRDXs were shown, the significant differences in their expressions (PRDX2 and PRDX6) or locations (PRDX1 and PRDX6) indicated their potential as new markers for COAD diagnosis. This evidence concerns the gene PRDX1 and colon adenocarcinoma.